PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Pulpitis

Drugs in development · updated 9 November 2026

Pulpitis: drugs in development

What it is

Pulpitis is inflammation of dental pulp tissue. The pulp contains the blood vessels, the nerves, and connective tissue inside a tooth and provides the tooth's blood and nutrients. Pulpitis is mainly caused by bacterial infection which itself is a secondary development of caries (tooth decay). It manifests itself in the form of a toothache.

Description not checked by Phuturdex: excerpt from the introduction of the article “Pulpitis” on English Wikipedia, en.wikipedia.org · version of 2 August 2026 · licence CC BY-SA 4.0.

As of 9 November 2026 there are 1 active clinical trials (recruiting or ongoing, phases I–III) on 4 drugs for pulpitis. 0 are experimental, that is not yet approved in the United States.

1Active trials
0Experimental drugs
0Experimental, in phase III

Summary updated every week · data as of 9 November 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
ArticaineCyklx®III1NCT07919938
DexamethasoneDexametasone, dexamethsoneIII1NCT07919938
DiclofenacVoltaren Topical Gel, Zueino®III1NCT07919938
EpinephrineAdrenaline, Epinephrine Bitartrate In 0.9% Sodium Chloride®III1NCT07919938

Sorted by most advanced phase and number of active trials.

All 4 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 9 November 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: NLM MeSH; NLM MeSH term: D011671 “Pulpitis”.

ItalianoFrançaisDeutsch